Latest Development Activity News

Cue Energy delivered a robust quarter with $4.3 million net cash flow and a $17.1 million cash balance, driven by strong drilling results and production growth across its Australian and Indonesian assets.

New Murchison Gold Limited reports a significant 39% increase in indicated gold resources at its Crown Prince deposit and secures a strategic ore purchase deal with Westgold, setting the stage for mining to commence mid-2025.

Mont Royal Resources Limited reported a stable cash position of $1.75 million at the end of December 2024, despite significant outflows on exploration activities during the quarter.

Gullewa Limited reports steady progress on its Hunter Valley subdivision and South Darlot gold exploration, alongside a significant royalty payment from Silver Lake Resources.

InVert Graphite Limited has secured shareholder approval for a transformative acquisition of a Tanzanian graphite project and rebranded from Dominion Minerals, positioning itself for a strategic relisting on the ASX.

Pure Hydrogen Corporation Limited is set to unlock value by spinning out its Australian gas assets into Eastern Gas Limited, offering shareholders free shares in the new entity. The move positions Eastern Gas to capitalize on strong East Coast gas market demand with an anticipated $8–10 million IPO.

McLaren Minerals is set to begin a six-week drilling campaign at its McLaren Titanium Project in Western Australia, aiming to boost resource confidence and explore deposit extensions.

ReNerve Limited has reported a remarkable 260% increase in quarterly sales following its successful IPO, alongside strategic distribution deals in Hong Kong and the Middle East. The company is poised for further growth with upcoming clinical data and product developments.

Jupiter Energy Limited reported a net operating cash inflow of $776,000 for the December 2024 quarter, maintaining a solid cash position despite heavy exploration expenditures.

Rox Resources has completed its $27 million capital raising with the final tranche of shares issued to institutional investors and company directors, signaling strong backing for its growth plans.

Red Hill Minerals reports a robust December quarter with $2.7 million in royalty revenue, a special dividend payout, and promising drilling results across multiple gold and base metal projects.

Neurizon Therapeutics reports encouraging 8-month interim results for its ALS drug NUZ-001, secures Orphan Medicinal Product Designation in Europe, and raises $885,000 through a share placement, maintaining a robust $14 million cash position.